TY - JOUR
T1 - Linking reminders and physician breast cancer screening recommendations
T2 - Results from a national survey
AU - Siembida, Elizabeth J.
AU - Radhakrishnan, Archana
AU - Nowak, Sarah A.
AU - Parker, Andrew M.
AU - Pollack, Craig Evan
N1 - Publisher Copyright:
© 2018 American Society of Clinical Oncology.
PY - 2017
Y1 - 2017
N2 - Purpose Physician reminders have successfully increased rates of mammography. However, considering recent changes to breast cancer screening guidelines that disagree on the optimal age to start and stop mammography screening, we sought to examine the extent to which reminders have been deployed for breast cancer screening targeting younger and older patients. Methods A mailed survey was sent to a national sample of 2,000 primary care physicians between May and September 2016. Physicians were askedwhether they received reminders to screen women in various age groups (40 to 44, 45 to 49, and ≥ 75 years), the organizational screening guidelines they trusted most, and whether they recommended routine breast cancer screening to average-riskwomenin the different age groups. Using regression models,weassessedtheassociationbetweenremindersandphysicianscreeningrecommendations,controlling for physician and practice characteristics, and evaluatedwhether the association varied by the guidelines they trusted. ResultsAtotal of 871physicians responded (adjusted response rate, 52.3%). Overall,28.9%of physicians reported receiving reminders for patient ages 40 to 44 years, 32.5% for patient ages 45 to 49 years, and 16.5% for patient ages ≥ 75 years. Receiving reminders significantly increased the likelihood of physicians recommending mammography screening. In adjusted analyses, 84% (95% CI, 77% to 90%) of physicians who received reminders recommended screening for women ages ≥ 75 versus 65% (95% CI, 62% to 69%) of those who did not receive reminders. The associations between reminders and screening recommendations remained consistent regardless of which guidelines physicians reported trusting. Conclusion Reminders were significantly associated with increases in physician screening recommendations for mammography, underscoring the need for careful implementation in scenarios where guidelines are discordant.
AB - Purpose Physician reminders have successfully increased rates of mammography. However, considering recent changes to breast cancer screening guidelines that disagree on the optimal age to start and stop mammography screening, we sought to examine the extent to which reminders have been deployed for breast cancer screening targeting younger and older patients. Methods A mailed survey was sent to a national sample of 2,000 primary care physicians between May and September 2016. Physicians were askedwhether they received reminders to screen women in various age groups (40 to 44, 45 to 49, and ≥ 75 years), the organizational screening guidelines they trusted most, and whether they recommended routine breast cancer screening to average-riskwomenin the different age groups. Using regression models,weassessedtheassociationbetweenremindersandphysicianscreeningrecommendations,controlling for physician and practice characteristics, and evaluatedwhether the association varied by the guidelines they trusted. ResultsAtotal of 871physicians responded (adjusted response rate, 52.3%). Overall,28.9%of physicians reported receiving reminders for patient ages 40 to 44 years, 32.5% for patient ages 45 to 49 years, and 16.5% for patient ages ≥ 75 years. Receiving reminders significantly increased the likelihood of physicians recommending mammography screening. In adjusted analyses, 84% (95% CI, 77% to 90%) of physicians who received reminders recommended screening for women ages ≥ 75 versus 65% (95% CI, 62% to 69%) of those who did not receive reminders. The associations between reminders and screening recommendations remained consistent regardless of which guidelines physicians reported trusting. Conclusion Reminders were significantly associated with increases in physician screening recommendations for mammography, underscoring the need for careful implementation in scenarios where guidelines are discordant.
UR - http://www.scopus.com/inward/record.url?scp=85077489503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077489503&partnerID=8YFLogxK
U2 - 10.1200/CCI.17.00090
DO - 10.1200/CCI.17.00090
M3 - Article
C2 - 30657396
AN - SCOPUS:85077489503
SN - 2473-4276
VL - 2017
SP - 1
EP - 10
JO - JCO Clinical Cancer Informatics
JF - JCO Clinical Cancer Informatics
IS - 1
ER -